Johnson & Johnson (JNJ) stock fell as the company lowered full-year earnings outlook while reporting better-than-expected Q3 ...

Johnson & Johnson (JNJ) is set to announce Q3 earnings on October 15th. Analysts expect profit of $2.21 on revenue of $22.17B ...

Johnson & Johnson shares rose 0.7% in premarket trades Tuesday after the drugmaker reported better-than-expected ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

We expect the company to post revenue of $22.2 billion and earnings of $2.20 per share, broadly aligning with the consensus ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Good morning, and welcome to Johnson & Johnson's third-quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at ...

Matt Miksic, an analyst from Barclays, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on third-quarter financial results and a surgical ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...